Over the last month and a half, the market has rebounded pretty strongly off of its bear market lows. Just as the slide that started in February as nations across the globe began imposing economic shutdowns and shelter-in-place orders to slow the COVID-19 infection rate affected just about every sector of the economy, so to […]
Read MoreBuy Price: $14.75 or better Sell Price: TradersPro Sell Signal Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies using protein design technology. The company’s lead product candidate is NL-201, a computationally-designed de novo protein therapeutic for the treatment of IL-2/IL-15 cancer immunotherapy. It also engages in research activities for the treatment of autoimmunity and allergy.
Read MorePlus, Sorrento Therapeutics is partnering with New York’s Mount Sinai on developing a antibody cocktail to shield health care workers and other front-line workers from the coronavirus, Tesla is resuming production at its Fremont, CA plant, and Disney shares got a boost from tickets selling out within minutes for the reopening of its Shanghai Disneyland park.
Read More